My Quote Request
6505-00-933-8965
20 Products
NDC00008-0268-01
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505009338965
NSN
6505-00-933-8965
NDC00008-0268-01
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505009338965
NSN
6505-00-933-8965
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 30.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
SPECIAL FEATURES: CONTROLLED SUBSTANCE CLASSIFICATION:SCHEDULE IV
SUPPLEMENTARY FEATURES: D-DAY ITEM FOR DOD
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
GANTAN0L
SULFAMETHOXAZOLE SUSPENSION
NSN, MFG P/N
6505009316617
NSN
6505-00-931-6617
MFG
HOFFMANN-LA ROCHE INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.100 GRAMS SULFAMETHOXAZOLE PER MILLILITER
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 PINTS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
ALDOMET
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00005-3850-34
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00005-3850-34
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00006-0401-82
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00006-0401-82
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
MERCK SHARP & DOHME CORP. DBA MERCK DIV US HUMAN HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00172-2931-80
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00172-2931-80
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
ZENITH LABORATORIES INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00182-1732-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00182-1732-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
GOLDLINE LABORATORIES INC. DBA GOLDLINE LABORATORIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00378-0611-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00378-0611-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
MYLAN PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00536-4021-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00536-4021-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00536-4553-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00536-4553-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00781-1320-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
NDC00781-1320-10
METHYLDOPA TABLETS,USP
NSN, MFG P/N
6505009316646
NSN
6505-00-931-6646
MFG
GENEVA PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS METHYLDOPA ACTIVE INGREDIENT
ADMINISTRATION: ORAL
FEATURES PROVIDED: ENTERIC COATED
III PART NAME ASSIGNED BY CONTROLLING AGENCY: METHYLDOPA TABLETS USP 0.25GM 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
2459
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505009317823
NSN
6505-00-931-7823
2459
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505009317823
NSN
6505-00-931-7823
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
ATARAX
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505009317823
NSN
6505-00-931-7823
ATARAX
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505009317823
NSN
6505-00-931-7823
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
NDC00049-5620-73
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505009317823
NSN
6505-00-931-7823
NDC00049-5620-73
HYDROXYZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505009317823
NSN
6505-00-931-7823
MFG
ROERIG DIV PFIZER INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MILLIGRAMS HYDROXYZINE HYDROCHLORIDE ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: COATING FEATURE:SUGAR
Related Searches:
LASIX INJECTION
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
LASIX INJECTION
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00039-0055-25
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
NDC00039-0055-25
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
MFG
HOECHST-ROUSSEL PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00074-6102-02
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
NDC00074-6102-02
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
NDC00641-0382-25
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
NDC00641-0382-25
FUROSEMIDE INJECTION,USP
NSN, MFG P/N
6505009338704
NSN
6505-00-933-8704
MFG
ELKINS-SINN INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS FUROSEMIDE PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 2.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL
Related Searches:
ID709
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505009338964
NSN
6505-00-933-8964
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: INDIVIDUALLY SEALED
TOTAL PRIMARY CONTAINER QUANTITY: 1
Related Searches:
NDC00008-0267-01
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505009338964
NSN
6505-00-933-8964
NDC00008-0267-01
PHENOBARBITAL TABLETS,USP
NSN, MFG P/N
6505009338964
NSN
6505-00-933-8964
MFG
AMERICAN HOME PRODUCTS CORP WYETH-AYERST LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 15.000 MILLIGRAMS PHENOBARBITAL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 25.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
SPECIAL FEATURES: INDIVIDUALLY SEALED
TOTAL PRIMARY CONTAINER QUANTITY: 1